RPG LIFE SCIENCES
Quarterly Results Analysis [Dec2023]
RPG LIFE SCIENCES Quarterly Results
Standalone | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹154 Cr | ₹154 Cr | ₹148 Cr | ₹118 Cr | ₹131 Cr | ₹135 Cr | ₹129 Cr | ₹104 Cr |
Expenses | ₹116 Cr | ₹116 Cr | ₹116 Cr | ₹103 Cr | ₹101 Cr | ₹105 Cr | ₹101 Cr | ₹90 Cr |
Operating Income | ₹38 Cr | ₹37 Cr | ₹32 Cr | ₹16 Cr | ₹29 Cr | ₹30 Cr | ₹28 Cr | ₹14 Cr |
Other Income | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
Profit Before Tax | ₹36 Cr | ₹35 Cr | ₹30 Cr | ₹14 Cr | ₹26 Cr | ₹27 Cr | ₹25 Cr | ₹11 Cr |
Profit After Tax | ₹26 Cr | ₹26 Cr | ₹22 Cr | ₹10 Cr | ₹19 Cr | ₹20 Cr | ₹18 Cr | ₹8 Cr |
EPS | ₹16.00 | ₹15.64 | ₹13.36 | ₹6.26 | ₹11.56 | ₹12.08 | ₹11.01 | ₹4.55 |
Industry Peers & Returns | 1W | 1M | 1Y |
RPG LIFE SCIENCES | 3.9% | 3.1% | 93.6% |
SUN PHARMACEUTICAL INDUSTRIES | -0.1% | -2.8% | 50.3% |
CIPLA | 4.5% | -3.1% | 52.8% |
DR REDDYS LABORATORIES | 4.6% | 1.4% | 22.2% |
ZYDUS LIFESCIENCES | 3.1% | -4.1% | 80.4% |
DIVIS LABORATORIES | 4.7% | 10.8% | 18.1% |
MANKIND PHARMA | 2.7% | 12.4% | NA |
TORRENT PHARMACEUTICALS | 6.1% | 5.3% | 66.2% |
LUPIN | 3.1% | -1.1% | 127.4% |
RPG LIFE SCIENCES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 0.08 % |
Y-o-Y | 17.69 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹154 Cr | 0.08 | |
Sep2023 | ₹154 Cr | 3.92 | |
Jun2023 | ₹148 Cr | 24.72 | |
Mar2023 | ₹118 Cr | -9.27 | |
Dec2022 | ₹131 Cr | -3.11 | |
Sep2022 | ₹135 Cr | 4.55 | |
Jun2022 | ₹129 Cr | 24.21 | |
Mar2022 | ₹104 Cr | - |
RPG LIFE SCIENCES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 1.64 % |
Y-o-Y | 29.75 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹38 Cr | 1.64 | |
Sep2023 | ₹37 Cr | 15.66 | |
Jun2023 | ₹32 Cr | 102.64 | |
Mar2023 | ₹16 Cr | -45.53 | |
Dec2022 | ₹29 Cr | -1.75 | |
Sep2022 | ₹30 Cr | 6.79 | |
Jun2022 | ₹28 Cr | 106.07 | |
Mar2022 | ₹14 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 1.57 % |
Y-o-Y | 10.24 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 24.66% | 1.57 | |
Sep2023 | 24.28% | 11.27 | |
Jun2023 | 21.82% | 62.47 | |
Mar2023 | 13.43% | -39.96 | |
Dec2022 | 22.37% | 1.41 | |
Sep2022 | 22.06% | 2.18 | |
Jun2022 | 21.59% | 65.82 | |
Mar2022 | 13.02% | - |
RPG LIFE SCIENCES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 2.32 % |
Y-o-Y | 38.46 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹26 Cr | 2.32 | |
Sep2023 | ₹26 Cr | 17.01 | |
Jun2023 | ₹22 Cr | 113.53 | |
Mar2023 | ₹10 Cr | -45.84 | |
Dec2022 | ₹19 Cr | -4.31 | |
Sep2022 | ₹20 Cr | 9.67 | |
Jun2022 | ₹18 Cr | 142.15 | |
Mar2022 | ₹8 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 2.26 % |
Y-o-Y | 17.70 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 17.22 % | 2.26 | |
Sep2023 | 16.84 % | 12.64 | |
Jun2023 | 14.95 % | 71.25 | |
Mar2023 | 8.73 % | -40.33 | |
Dec2022 | 14.63 % | -1.28 | |
Sep2022 | 14.82 % | 4.96 | |
Jun2022 | 14.12 % | 95.03 | |
Mar2022 | 7.24 % | - |
RPG LIFE SCIENCES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 2.30 % |
Y-o-Y | 38.41 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹16 | 2.30 | |
Sep2023 | ₹15.64 | 17.07 | |
Jun2023 | ₹13.36 | 113.42 | |
Mar2023 | ₹6.26 | -45.85 | |
Dec2022 | ₹11.56 | -4.30 | |
Sep2022 | ₹12.08 | 9.72 | |
Jun2022 | ₹11.01 | 141.98 | |
Mar2022 | ₹4.55 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD